Cargando…
Assessment of Adverse Events in Protocols, Clinical Study Reports, and Published Papers of Trials of Orlistat: A Document Analysis
BACKGROUND: Little is known about how adverse events are summarised and reported in trials, as detailed information is usually considered confidential. We have acquired clinical study reports (CSRs) from the European Medicines Agency through the Freedom of Information Act. The CSRs describe the resu...
Autores principales: | Schroll, Jeppe Bennekou, Penninga, Elisabeth I., Gøtzsche, Peter C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4987052/ https://www.ncbi.nlm.nih.gov/pubmed/27529343 http://dx.doi.org/10.1371/journal.pmed.1002101 |
Ejemplares similares
-
Challenges in Coding Adverse Events in Clinical Trials: A Systematic Review
por: Schroll, Jeppe Bennekou, et al.
Publicado: (2012) -
Searching for unpublished data for Cochrane reviews: cross sectional study
por: Schroll, Jeppe Bennekou, et al.
Publicado: (2013) -
Human Papillomavirus Testing in the Last Cervical Screening Round at Age 60–64 Years
por: Schroll, Jeppe Bennekou, et al.
Publicado: (2021) -
Dealing with substantial heterogeneity in Cochrane reviews. Cross-sectional study
por: Schroll, Jeppe B, et al.
Publicado: (2011) -
Comparison of orlistat and orlistat plus metformin therapy between diabetic and nondiabetic groups
por: Gunay, Yasemin Emur, et al.
Publicado: (2023)